Opportunity: "How on God's green Earth can someone with authority blatantly say such a thing if it was not true? Are you saying this is all semantics? It would not only be unjust, it would most certainly be criminal. I am not seeing your logic to shoot first and then ask questions. Why not give Dr Moro a chance to answer before you sell at these ridiculous levels? We are now literally scraping the bottom."
Sorry for the delay in answering but I ran out of free posts for the day. I would be much more happy with an answer from Dr. Moro than Wittenberg. Wittenberg has nothing to do with running of the company and may in fact not be fully informed. There are problems involved with Wittenberg and his non BioCurex activities.
One of the problems Abbott had with RECAF is the difficulty of getting it on the analyzer. Abbott had given up and Dr. Moro had assumed all the development in mid 2006. At that point, there was no one left at Abbott to champion RECAF. RECAF was like a homeless person wandering the halls of Abbott. When Dr. Moro perfected the test, he ran samples for presentation. He sent the test kit to Abbott and they ran samples. The ISOBM results showed a cancer/normal ration of 1.7 for Dr. Moro's samples of various cancers. Abbott ran tests for prostate cancer, probably using samples with benign tumors where RECAF does not perform that well. Their cancer/normal ratio was 1.3. When you get to 1.0, you can probably flip a coin. Abbott wasn't too happy with those results. My guess is that RECAF just sat at Abbott for several more months doing nothing until someone realized a minimum royalty payment would be due Mar 1. We can only guess what happened after that but one thing for sure, Abbott is running lean on money right now and management would want to stop any unnecessary expenditures. Pairing RECAF with the PSA test would definitely improve results but obviously not to the satisfaction of Abbott.
Why have I decided to sell? Abbott dumping RECAF was a huge setback for a near term profit picture but that's only the trigger. The reason to sell is Smithline. He is absolutely manipulating this stock and selling on every news item right back down to 60 cents. I know that 60 cents is a long ways off right now but it is a fact of life that he has a lid on this stock. The stock will not break out until strong profits move the stock price enough that it forces the exercise of his 3.5 million warrants. At that point, the stock would be in the clear.
Now the question is how to survive and get the stock price back up. Smithline is a huge problem and it is going to take 2 million dollars just to service his debt next year let alone money needed to operate. The point is, why ride this to zero if it is going to fail? If by the end of the year, Dr. Moro signs another licensee and comes up with 3 million to survive, I can buy back in but not until the price is up to 60 cents and closer to profits. I just will not take the risk and buy back the number of shares I previously held. If the company is sold for more than the current price, I lose but that's a chance you take. I hope that adequately explains my position.
In retrospect, I should have sold when I indeed saw Smithline shorting the stock extensively.
Opportunity: "How on God's green Earth can someone with authority blatantly say such a thing if it was not true? Are you saying this is all semantics? It would not only be unjust, it would most certainly be criminal. I am not seeing your logic to shoot first and then ask questions. Why not give Dr Moro a chance to answer before you sell at these ridiculous levels? We are now literally scraping the bottom."
Sorry for the delay in answering but I ran out of free posts for the day. I would be much more happy with an answer from Dr. Moro than Wittenberg. Wittenberg has nothing to do with running of the company and may in fact not be fully informed. There are problems involved with Wittenberg and his non BioCurex activities.
One of the problems Abbott had with RECAF is the difficulty of getting it on the analyzer. Abbott had given up and Dr. Moro had assumed all the development in mid 2006. At that point, there was no one left at Abbott to champion RECAF. RECAF was like a homeless person wandering the halls of Abbott. When Dr. Moro perfected the test, he ran samples for presentation. He sent the test kit to Abbott and they ran samples. The ISOBM results showed a cancer/normal ration of 1.7 for Dr. Moro's samples of various cancers. Abbott ran tests for prostate cancer, probably using samples with benign tumors where RECAF does not perform that well. Their cancer/normal ratio was 1.3. When you get to 1.0, you can probably flip a coin. Abbott wasn't too happy with those results. My guess is that RECAF just sat at Abbott for several more months doing nothing until someone realized a minimum royalty payment would be due Mar 1. We can only guess what happened after that but one thing for sure, Abbott is running lean on money right now and management would want to stop any unnecessary expenditures. Pairing RECAF with the PSA test would definitely improve results but obviously not to the satisfaction of Abbott.
Why have I decided to sell? Abbott dumping RECAF was a huge setback for a near term profit picture but that's only the trigger. The reason to sell is Smithline. He is absolutely manipulating this stock and selling on every news item right back down to 60 cents. I know that 60 cents is a long ways off right now but it is a fact of life that he has a lid on this stock. The stock will not break out until strong profits move the stock price enough that it forces the exercise of his 3.5 million warrants. At that point, the stock would be in the clear.
Now the question is how to survive and get the stock price back up. Smithline is a huge problem and it is going to take 2 million dollars just to service his debt next year let alone money needed to operate. The point is, why ride this to zero if it is going to fail? If by the end of the year, Dr. Moro signs another licensee and comes up with 3 million to survive, I can buy back in but not until the price is up to 60 cents and closer to profits. I just will not take the risk and buy back the number of shares I previously held. If the company is sold for more than the current price, I lose but that's a chance you take. I hope that adequately explains my position.
In retrospect, I should have sold when I indeed saw Smithline shorting the stock extensively.
Longterm: "hi Gold Seeker. i saw that your are selling. sorry to hear that in a way. but that might bring the s/p down some more, and i will buy some of those shares, all i can"
Hi LT, if you read this, you have obviously read my post above. I am not going to give the shares away nor drive the price in the dirt. Good luck buying some and wish you luck. You better rub that rabbits foot on this one.
News 
Market Data 
Discover 
